Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
anti MAG antibodies
aphasia
area postrema
atypical
autoantibodies
bradycardia
brain biopsy
brain biopsy, false negative
brain biopsy, indication
brainstem, lesion of
CAT scan
CAT scan, abnormal
CAT scan, demyelinating disease
CAT scan, mass effect on
CAT scan, ring sign
cerebellar peduncle
cerebral edema
cerebral peduncle
cerebrospinal fluid, abnormal
complications
cyst, cortical parenchyma
delay in diagnosis
demyelinating disease
diagnostic criteria
diencephalon
differential diagnosis
drug induced neurologic disorders
encephalitis
encephalomyelitis, postinfectious
fingolimod
fourth ventricle, floor
gadolinium
gammaglobulin therapy, intravenous
glioma
headache
hemiparesis
hypothalamus, lesion of
iatrogenic neurologic disorders
immunomodulation
immunosuppression
leukopenia
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
macular edema
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
misdiagnosis
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, mass effect on
MRI, ring sign
MRI, ring sign, open
MRS
multiple sclerosis
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, misdiagnosis
multiple sclerosis, treatment of
multiple sclerosis, tumefactive
myelitis, longitudinal
nausea and vomiting
neoplasm, intracranial
neoplasm, metastatic to CNS
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
periaqueductal lesion
plasmapheresis
prognosis
progressive neurologic disorder
pseudotumor
recurrent
review article
seizure
single photon emission computed tomography
single photon emission computed tomography, thallium
steroid therapy, CNS treatment and complications with
sweet taste
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
thalamus, lesion of
thalamus, lesion of-bilateral
third ventricle, wall
transient neurologic deficit
treatment of neurologic disorder
tumefactive lesion
vaccination, neurologic complications with
Virchow-Robin spaces, dilated
water channel antibodies
white matter disease
workup
Showing articles 600 to 650 of 4058 << Previous Next >>

Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004

The Effect of Cannabis on Tremor in Patients with Multiple Sclerosis
Neurol 62:1105-1109, Fox,P.,et al, 2004

Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004

Progressive Binasal Hemianopia
Lancet 363:1606, Pringle,E.,et al, 2004

Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004

Randomized Controlled Trial of Yoga and Exercise in Multiple Sclerosis
Neurol 62:2058-2064, Oken,B.S.,et al, 2004

Familial Multiple Sclerosis and Other Inherited Disorders of the White Matter
The Neurologist 10:201-215, Kalman,B. &Leist,T.P., 2004

Role of Magnetic Resonance Imaging Within Diagnostic Criteria for Multiple Sclerosis
Ann Neurol 56:273-278, Miller,D.H.,et al, 2004

Clinical Implications of Benign Multiple Sclerosis: A 20-Year Population-Based Follow-Up Study
Ann Neurol 56:303-306, Pittock,S.J.,et al, 2004

Neurologic Impairment 10 Years After Optic Neuritis
Arch Neurol 61:1386-1389, Optic Neuritis Study Group, 2004

The Natural History of Recurrent Optic Neuritis
Arch Neurol 61:1401-1405, Pirko,I.,et al, 2004

European Study on Intravenous Immunoglobulin in Multiple Sclerosis
Arch Neurol 61:1409-1412, Filippi,M.,et al, 2004

The Prevalence of Pain in Multiple Sclerosis, A Multicenter Cross-Sectional Study
Neurol 63:919-921, Solaro,C.,et al, 2004

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol 61:222-224, Sastre-Garriga,J.,et al, 2004

Infratentorial Lesions Predict Long-term Disability in Patients with Initial Findings Suggestive of Multiple Sclerosis
Arch Neurol 61:217-221, Minneboo,A.,et al, 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Susac Syndrome:Report of Four Cases and Review of the Literature
AJNR 25:382-388,351, Do,T.H.,et al, 2004

Acute Aphasia in Multiple Sclerosis, A Multicenter Study of 22 Patients
Neurol 62:974-977, Lacour,A.,et al, 2004

Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Vasculitis of the Spinal Cord
Arch Neurol 60:1791-1794, Ropper,A.H.,et al, 2003

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

A Wallerian Degeneration Pattern in Patients at Risk for MS
Neurol 54:1155-1160, Simion,J.H.,et al, 2003

Spinal Cord MRI in Clinically Isolated Optic Neuritis
JNNP 74:1577-1580, Dalton,C.M.,et al, 2003

Multiple Sclerosis Presenting as Lower Motor Neuron Wasting and Weakness of the Distal Upper Extremity
Neurol 61:1303-1304, Chong,P.S.T.,et al, 2003

Smoking is a Risk Factor for Multiple Sclerosis
Neurol 61:1122-1124, Riise,T.,et al, 2003

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003

MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles
AJNR 24:1946-1954, Okamoto,K.,et al, 2003

Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis
AJNR 24:1935-1940,1929, Ge,Y.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Three Subsequent Single Doses of Gadolinum Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR 24:658-662, Sardanelli,F.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

A Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial Registered Magnetic Resonance Imaging
Arch Neurol 60:989-994, Scahill,R.I.,et al, 2003

Pain in Patients with Multiple Sclerosis
Arch Neurol 60:1089-1094, Svendsen,K.B.,et al, 2003

Peripheral Third Cranial Nerve Enhancement in Multiple Sclerosis
AJNR 24:1390-1395, Bhatti,M.T.,et al, 2003

The Utility of MRI in Suspected MS, Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 61:602-611,596, Frohman,E.M.,et al, 2003

Seizure Remission and Antiepileptic Drug Discontinuation in Children with Tuberous Sclerosis Complex
Arch Neurol 60:1286-1289, Sparagana,S.P.,et al, 2003

Self Reported Stressful Life Events and Exacerbations in Multiple Sclerosis:Prospective Study
BMJ 327:646-649, Beljevac,D.,et al, 2003

Concurrence of Multiple Sclerosis and Intracranial Glioma. Report of a Case and Review of the Literature.
Clin Neuropathol 22:304-308, Shuangshoti,S.,et al, 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003



Showing articles 600 to 650 of 4058 << Previous Next >>